The Lewin Group Appoints Dr. Paul J. Wallace Director of the Center for Comparative Effectiveness Research
May 16, 2011
Leads a portfolio of key federal CER projects for Health and Human Services, Center for Medicare & Medicaid Services, Food & Drug Administration and Agency for Healthcare Research and Quality
FALLS CHURCH Va. – May 17, 2011 – Paul J. Wallace, M.D., has joined The Lewin Group as senior vice president and director of its Center for Comparative Effectiveness Research (CER).
||A board-certified physician in internal medicine and hematology, Dr. Wallace most recently was medical director for health and productivity management programs at Kaiser Permanente’s national Permanente Federation. He served as a physician and administrator with Kaiser for more than 20 years. Prior to his work at Kaiser, he served as a faculty member at Oregon Health & Science University (OHSU), where he investigated bone marrow function and taught clinical and basic sciences.
Dr. Wallace is a recognized expert on CER-related topics including evidence-based medicine practice and policy; clinical performance measurement and improvement; clinical practice guideline development; population-based care and disease management; and comparative assessments of technologies and other interventions.
CER compares the impact of different health care interventions to determine which work best for patients, and is a critical component of improving patient care and health outcomes nationwide. The federal government also refers to CER as patient-centered outcomes research (PCOR), and broadened its support for this research as part of health care and stimulus legislation passed in 2009 and 2010.
Dr. Wallace helps guide health policy at the U.S. national level, in part through his roles on advisory committees at the Institute of Medicine (IOM), where he serves as a member of the Board on Population Health and Public Health Practice; the Committee for Systematic Reviews of Clinical Effectiveness Research; and the Coordinating Committee for Developing Trustworthy Clinical Practice Guidelines. He also is a member of the board of directors of AcademyHealth and the Society for Participatory Medicine.
“Our Center combines research, information and consulting acumen to strengthen our national capacity to conduct high-priority CER and make our findings about what works in health care widely available to patients, clinicians, provider institutions, private and public payers, employers and others,” said Dr. Wallace. “I am excited about the opportunity to lead this organization as we help advance new understanding about health care innovations ─ in pharma, biotech, devices, medical and surgical procedures, and the organization, delivery and financing of care.”
Dr. Wallace previously served on the National Advisory Committee for the Agency for Healthcare Research and Quality (AHRQ); the Medicare Coverage Advisory Committee, Centers for Medicare & Medicaid Services (CMS); the Committee on Performance Measurement for the National Committee on Quality Assurance (NCQA); and the Center for Management of Complex Chronic Care at the Veterans Administration in Chicago. He is a graduate of the University of Iowa School of Medicine and completed further training in Internal Medicine and Hematology at Strong Memorial Hospital and the University of Rochester.
“The Lewin Group has established a strong portfolio at the core of advancing the national CER enterprise, and with Paul’s expertise and leadership we are already working to enhance our Center’s contribution throughout the health sector,” said Lisa Chimento, CEO of The Lewin Group.
The Lewin Group Center for CER is playing a key role in six new federal health care projects designed to improve patient outcomes through more evidence-based practice and policies, and will enable researchers and others to access powerful new data sources and tools to strengthen national CER efforts. These include work with the Department of Health and Human Services Office of the Assistant Secretary for Planning and Evaluation (ASPE), the Centers for Medicare & Medicaid Services (CMS), the Agency for Healthcare Research and Quality (AHRQ), and the Food and Drug Administration (FDA).
About The Center for Comparative Effectiveness Research and The Lewin Group
The Lewin Group Center for Comparative Effectiveness Research was created in 2009 to help support federal efforts to improve patient health outcomes and health care delivery through the development of data-driven and evidence-based findings. The Lewin Center brings together its own health care policy and management consulting expertise and patient-level health data assets from Ingenix, a health care information, technology and consulting services company, regarding approaches for implementing CER and evaluating its impact. The Lewin Group works with government, private sector and academic institutions to establish CER programs, design and facilitate appropriately conducted research, provide access to data sets required for sound CER programs, and interpret and communicate CER findings. This research can inform the decisions that help achieve the most effective patient outcomes, health care policies and deployment of health care resources. For more information, visit www.lewin.com/cer.
The Lewin Group is a premier national health care and human services consulting firm with more than 40 years’ experience finding answers and solving problems for leading organizations in the public, nonprofit and private sectors. For more information on The Lewin Group, visit www.lewin.com. The Lewin Group is an Ingenix company.
The Lewin Group operates with editorial independence and provides its clients the very best expert and impartial health care and human services policy research and consulting services.